Anúncio
Anúncio
VNDA
Vanda Pharmaceuticals Inc.
7.32
USDPatrocinado
-0.02
-0.23%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
7.37
+0.04
+0.57%
Relatórios de Lucros VNDA
Rácio de surpresa positiva
VNDA separação 28 de 38 últimas estimativas.
74%
Próximo Relatório
Data do Próximo Relatório
11 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$60.46M
/-$0.99
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+7.47%
/+160.53%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+13.68%
/+1137.50%
Vanda Pharmaceuticals Inc. earnings per share and revenue
On 29 de out. de 2025, VNDA reported earnings of -0.38 USD per share (EPS) for Q3 25, beating the estimate of -0.46 USD, resulting in a 17.82% surprise. Revenue reached 56.26 milhão, compared to an expected 59.91 milhão, with a -6.09% difference. The market reacted with a -20.15% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.99 USD, with revenue projected to reach 60.46 milhão USD, implying an aumentar of 160.53% EPS, and aumentar of 7.47% in Revenue from the last quarter.
FAQ
What were Vanda Pharmaceuticals Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Vanda Pharmaceuticals Inc. reported EPS of -$0.38, beating estimates by 17.82%, and revenue of $56.26M, -6.09% below expectations.
How did the market react to Vanda Pharmaceuticals Inc.'s Q3 2025 earnings?
The stock price moved down -20.15%, changed from $5.41 before the earnings release to $4.32 the day after.
When is Vanda Pharmaceuticals Inc. expected to report next?
The next earning report is scheduled for 11 de fev. de 2026.
What are the forecasts for Vanda Pharmaceuticals Inc.'s next earnings report?
Based on 6
analistas, Vanda Pharmaceuticals Inc. is expected to report EPS of -$0.99 and revenue of $60.46M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio